Opaleye Management as of March 31, 2023
Portfolio Holdings for Opaleye Management
Opaleye Management holds 41 positions in its portfolio as reported in the March 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Harrow Health (HROW) | 23.9 | $80M | 3.8M | 21.16 | |
| Ocular Therapeutix (OCUL) | 9.6 | $32M | 6.1M | 5.27 | |
| Tela Bio (TELA) | 6.6 | $22M | 2.1M | 10.64 | |
| Rhythm Pharmaceuticals (RYTM) | 3.9 | $13M | 735k | 17.84 | |
| Crinetics Pharmaceuticals In (CRNX) | 3.8 | $13M | 786k | 16.06 | |
| Karyopharm Therapeutics (KPTI) | 3.3 | $11M | 2.8M | 3.89 | |
| Keros Therapeutics (KROS) | 3.0 | $10M | 238k | 42.70 | |
| Tracon Pharmaceuticals Com New (TCON) | 2.7 | $9.0M | 4.8M | 1.89 | |
| Eton Pharmaceuticals (ETON) | 2.5 | $8.4M | 2.2M | 3.85 | |
| Protara Therapeutics Com Stk (TARA) | 2.4 | $8.1M | 2.7M | 3.00 | |
| Biohaven (BHVN) | 2.2 | $7.4M | 540k | 13.66 | |
| Cytokinetics Com New (CYTK) | 2.2 | $7.3M | 208k | 35.19 | |
| Kalvista Pharmaceuticals (KALV) | 2.2 | $7.3M | 923k | 7.86 | |
| Vaxcyte (PCVX) | 2.0 | $6.6M | 177k | 37.48 | |
| Larimar Therapeutics (LRMR) | 1.9 | $6.3M | 1.4M | 4.53 | |
| Theravance Biopharma (TBPH) | 1.8 | $5.9M | 546k | 10.85 | |
| Arcutis Biotherapeutics (ARQT) | 1.7 | $5.5M | 502k | 11.00 | |
| 4d Molecular Therapeutics In (FDMT) | 1.6 | $5.4M | 314k | 17.19 | |
| Jounce Therapeutics | 1.6 | $5.3M | 2.9M | 1.85 | |
| Marinus Pharmaceuticals Com New (MRNS) | 1.6 | $5.3M | 765k | 6.90 | |
| Xoma Corp Del Com New (XOMA) | 1.5 | $5.1M | 243k | 21.11 | |
| Edgewise Therapeutics (EWTX) | 1.5 | $5.0M | 750k | 6.67 | |
| Morphosys Sponsored Ads (MOR) | 1.4 | $4.7M | 1.2M | 3.96 | |
| Ideaya Biosciences (IDYA) | 1.4 | $4.7M | 343k | 13.73 | |
| Urogen Pharma (URGN) | 1.4 | $4.7M | 505k | 9.24 | |
| Theseus Pharmaceuticals | 1.3 | $4.3M | 488k | 8.88 | |
| Edap Tms S A Sponsored Adr (EDAP) | 1.3 | $4.2M | 382k | 11.07 | |
| Astria Therapeutics (ATXS) | 1.2 | $4.1M | 302k | 13.56 | |
| Liquidia Corporation Com New (LQDA) | 1.2 | $4.0M | 575k | 6.91 | |
| Fortress Biotech | 1.1 | $3.8M | 4.6M | 0.82 | |
| Phathom Pharmaceuticals (PHAT) | 1.1 | $3.5M | 496k | 7.14 | |
| Codexis (CDXS) | 0.9 | $3.1M | 750k | 4.14 | |
| Iovance Biotherapeutics (IOVA) | 0.8 | $2.6M | 421k | 6.11 | |
| Relay Therapeutics (RLAY) | 0.6 | $2.1M | 126k | 16.47 | |
| Kezar Life Sciences (KZR) | 0.6 | $2.0M | 625k | 3.13 | |
| Mineralys Therapeutics (MLYS) | 0.5 | $1.8M | 115k | 15.66 | |
| Stereotaxis Com New (STXS) | 0.5 | $1.8M | 867k | 2.04 | |
| Trevi Therapeutics (TRVI) | 0.5 | $1.5M | 836k | 1.85 | |
| Proqr Therapeutics Nv Shs Euro (PRQR) | 0.4 | $1.4M | 653k | 2.13 | |
| Nyxoah S A SHS (NYXH) | 0.1 | $430k | 58k | 7.47 | |
| Modular Medical Com New (MODD) | 0.1 | $266k | 184k | 1.45 |
